United States newsroom

NORTHBROOK, Ill., June 9, 2015 /PRNewswire/ -- Astellas today announced that Tarsis Lopez has been appointed to the role of associate director, external and digital communications, as part of the...

NORTHBROOK, Ill., (June 4, 2015) — The Astellas USA Foundation today announced joining the American Red Cross Disaster Responder Program, which gathers donations in advance of major disasters to...

NORTHBROOK, Ill. and ASPEN, Colo., June 4, 2015 /PRNewswire/ -- The Chris Klug Foundation (CKF) is pleased to announce the winners of the second annual Bounce Back Award, presented by Astellas....

TOKYO and NORTHBROOK, Ill., June 1, 2015 /PRNewswire/ -- Astellas Pharma Inc. (Tokyo: 4503) announced that data from a Phase 2 study evaluating the investigational use of enzalutamide as a single...

Data Presented in Plenary Session at AUA 2015 TOKYO and NEW ORLEANS, May 17, 2015 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503) announced today that results from its Phase 3b BESIDE clinical...

NORTHBROOK, Ill., May 14, 2015 /PRNewswire/ -- Astellas today announced several abstracts across multiple cancers that will be presented at the 2015 American Society of Clinical Oncology (ASCO)...

NORTHBROOK, Ill., May 13, 2015 /PRNewswire/ -- This year, Astellas commemorates its 10th anniversary by saluting a decade of milestones in patient health, volunteerism and scientific...

CHICAGO (Tuesday, May 12, 2015) – USA Rugby CEO Nigel Melville announced today that the USA Rugby Eagles will make their return to Soldier Field against the Australian Wallabies in a Saturday,...

NORTHBROOK, Ill., May 5, 2015 /PRNewswire/ -- Astellas announced that two abstracts detailing clinical data from studies of enzalutamide and one abstract detailing clinical data from a study of...

NORTHBROOK, Ill., April 27, 2015 /PRNewswire/ -- Astellas announced today that CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, is now available in the United States for the...

Isolation and lack of one-on-one peer connection is the largest challenge facing millennial cancer patients and caregivers 15-39 years old NEW YORK and NORTHBROOK, Ill. (April 27, 2015) – The...

NORTHBROOK, Ill., April 23, 2015 /PRNewswire/ -- Astellas announced today that seven abstracts will be presented on CRESEMBA® (isavuconazonium sulfate), the prodrug for isavuconazole, at the 25th...

TOKYO, April 6, 2015 /PRNewswire/ -- Astellas ("Astellas,") (Tokyo: 4503) today announced that Dr. Shontelle Dodson has been named vice president, Medical Excellence, Medical Affairs. Dodson will...

Nominations now being accepted for the award, which will be presented in December at a special event in Aspen, Colorado NORTHBROOK, Ill. and ASPEN, Colo., April 1, 2015 /PRNewswire/ -- Astellas...

Northbrook, Ill. March 26, 2015 – The Astellas USA Foundation today reaffirmed its commitment to inspiring the next generation of scientists by awarding grants to the Museum of Science and...

Northbrook, IL, March 25, 2015 –Astellas (www.astellas.us) has become a national corporate partner of The Trevor Project (www.thetrevorproject.org) to help advance the shared mission of ending...

NORTHBROOK, Ill., March 25, 2015 – Astellas, a leading pharmaceutical company based in Northbrook, Ill., has been named one of America’s Best Employers in the biotechnology industry by Forbes...

NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN)...

NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of CRESEMBA®...

Funding will support measles vaccination campaigns in Latin America Washington, D.C. March 5, 2015 – The United Nations Foundation’s Shot@Life Campaign, which helps expand access to...

Astellas is Exclusive Health Sponsor of the 'Ticket2Health' Initiative Promoting a Game Plan for Better Health and Wellness NORTHBROOK, Ill., Feb. 20, 2015 /PRNewswire/ -- Astellas Pharma US,...

NORTHBROOK, Ill., Feb. 19, 2015 /PRNewswire/ -- Astellas announces organizational and personnel changes in the Americas, highlighting the Company's focus on international markets, while also...

NORTHBROOK, Ill., Feb. 13, 2015 /PRNewswire/ -- Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its...

NORTHBROOK, Ill., Jan. 22, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration's (FDA) Anti-infective Drugs Advisory Committee voted unanimously to recommend...

NORTHBROOK, Ill., Dec. 18, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 33rd Annual J.P. Morgan...